Continuing Pharmacy Education for Pharmacy Professionals
Raabe College is committed to assuring that all students receive the finest education possible and is now offering continuing education to pharmacy professionals through distance learning methods. Our faculty members are dedicated scholars with a desire to assist student learning. We welcome your inquiries regarding the profession and our academic program. To learn more, click on any of the listings below.
NOTE: Registering for courses has changed. Once you login to pay for your course, you must remember to write down the enrolment key. You will need the enrolment key to access your course(s). If you already have an enrolment key, click here to access our new course management site.
May 2009 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
Universal Program Number: 048-000-09-017-H03-P
This CE is approved for Ohio Juris Prudence
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Description:
This issue of the Law & Mortar continues a series of articles exploring the aberrant practices of businesses that develop, manufacture, and sell prescription drugs at wholesale or retail, as well as those businesses providing professional services by health care professionals. This article focuses on compounding pharmacy practice.
Objectives:
- Define compounding by pharmacists and explain when it is appropriate
- List the types of compounding pharmacies and how they differ
- Explain the various federal and state laws and rules affecting compounding by pharmacists
- List the organizations that provide standards, as well as accreditation/certification of compounding pharmacists and pharmacies
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
Spring 2009 Ampule - If you've submitted a hardcopy quiz, credit can only be issued once.
Universal Program Number: 048-000-09-009-H04-P
Lindsay Snyder, PharmD, Pharmacy Practice resident, Blanchard Valley Medical Associates; Teresa Hoffman, PharmD, site preceptor; and Kelly Shields, PharmD, drug information specialist, ONU preceptor
Objectives:
- Define inactive ingredients
- Describe the purpose of inactive ingredients
- Identify populations in which inactive ingredients are
of concern
- Recognize potential inactive ingredient problems in
those populations
- Formulate a plan to respond to inquiries about inactive
ingredients
November 2008 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
This CE is approved for Ohio Juris Prudence.
Universal Program Number: 048-000-08-045-H03-P
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Objectives:
At the completion of this program, the participant will be able to:
- Explain the application of general business principles to the health care industry.
- Identify federal and state government agencies impacting development, manufacture and legal distribution of pharmaceuticals.
- Describe the background of patent law and list specific examples that apply to pharmaceutical manufacturers maintaining economic advantage.
- Outline the adoption and repeal of state anti-substitution laws.
-. List effective prescription drug marketing strategies.
August 2008 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
This CE is approved for Ohio juris prudence.
Universal Program Number: 048-000-08-035-H03-P
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Objectives:
At the completion of this program, the participant will be able to:
- Explain the application of general business principles to the health care industry.
- Identify federal and state government agencies impacting development, manufacture and legal distribution of pharmaceuticals.
- Describe the background of patent law and list specific examples that apply to pharmaceutical manufacturers maintaining economic advantage.
- Outline the adoption and repeal of state anti-substitution laws.
-. List effective prescription drug marketing strategies.
Fall 2008 Ampule - If you've submitted a hardcopy quiz, credit can only issued once.
Universal Program Number: 048-000-08-042-H103-P
Danielle Fennema, PharmD, Pharmacy Practice Resident at Physicians Inc/Ohio Northern University
With: Michael Rush, PharmD, Preceptor at Physicians Inc and Kelly Shields, PharmD, Director of Drug Information Services at Ohio Northern University
This article is designed to provide a brief review of heart failure and its major components that include pathophysiology, causes, diagnosis and testing, heart failure classifications, and treatments. The treatment options are divided into non-pharmacologic versus pharmacologic.
Objectives:
At the completion of this program, the participant will be able to:
- Recognize signs and symptoms of left and right ventricular heart failure.
- Identify causes of heart failure.
- List the ACC/AHA heart failure stages.
- Recognize the clinical trials supporting the ACC/AHA heart failure guidelines.
- The material presented was unbiased.
February 2008 Law & Mortar Newsletter - If you've submitted a hardcopy quiz, credit can only be issued once.
ACPE number: 048-000-08-016-H03-P
This CE is approved for Ohio Juris Prudence.
Dr. Wickham, previous Director of Pharmacy Law Institute, discusses the new rules adopted by the State Medical Board regarding the prescribing of drugs by physician assistants (PAs). This CE is approved by the Ohio State Board of Pharmacy for Juris Prudence.
Objectives:
-Explain the legislation outlining the physician assistant (PA) scope of practice and prescriptive authority, and the purpose of the Quick Summary of Physician Asssistant Prescriptive Authority.
-Describe the format of the proposed physician assistant (PA) Formulary and current rule status.
-State the types of PA supervision and requirements, and prescriptive restrictions of the supervisory plan.
-List information available on PAs on the State Medical Board website through the Ohio e-License Center.
-Specify how pharmacists verify the PA's prescriptive authority and validity of PA-generated prescriptions.
Universal Program Number: 048-000-07-030-H01-P
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Dr. Martin, Assistant Professor of Pharmacy Practice, discusses the definition, prevention, pharmacologic therapy, and non-pharmacologic therapy for migraine headaches.
Objectives:
-Describe current trends in the use of pharmacotherapy for migraine prevention.
-Explain the indications for, goals of, and potential benefits of the use of pharmacotherapy for migraine prevention.
-Explain factors to consider in the use and selection of pharmacotherapy for migraine prevention.
-Identify pros and cons of the currently available pharmacologic options for migraine prevention.
-Describe how to assess efficacy and tolerability of medications used in migraine prevention.
-Educate patients on the use of both acute and preventive migraine pharmacotherapy.
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Dr. Roecker, Associate Professor of Pharmacy Practice, discusses the epidemiology, at risk populations, pathogenesis, and treatment of community acquired pneumonia.
Objectives:
At the completion of this program, the participant will be able to:
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Dr. Shields, Assistant Professor of Pharmacy Practice, Director of The Drug Information Center, discusses the use, epidemiology, product regulation, purity, standardization, information resources, and pharmacists' role regarding dietary supplements.
Objectives:
At the completion of this program, the participant will be able to:
-Describe the prevalence and factors impacting patient use of dietary supplements.
-Identify issues of product quality related to dietary supplements.
-Identify current programs assessing product quality.
-Describe the role of the pharmacist in providing care to patients using supplements.
-Describe patient communication techniques for patients using supplements.
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Dr. Stockert, assistant professor of biochemistry, reviews enzyme catalysis, transition state theory, and enzyme kinetics.
Objectives:
At the completion of this program, the participant will be able to:
-Review the basics of enzyme catalysis including transition state theory.
-List four major methods utilized by enzymes for stabilization of the transition state: 1) proximity effects 2) acid-base catalysis 3) covalent catalysis 4) strain.
-Differentiate between steady state and pre-steady state kinetics.
-Differentiate between zero-order and first-order kinetics on the Michaelis-Menton graph.
-Given a Michaelis-Menton graph or Lineweaver-Burke plot, identify the Vmax and Km.
-List three classes of inhibitors: 1) competitive 2) non-competitive and 3) un-competitive.
-Given a Michaelis-Menton graph or Lineweaver-Burke plot, identify the type of inhibition.
-List the necessity of pre-steady state kinetics for design of mechanism based inhibitors.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
Universal Program Number: 048-000-07-028-L01-P
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Dr. Roecker, Associate Professor of Pharmacy Practice, discusses the epidemiology, at risk populations, pathogenesis, and treatment of community acquired pneumonia.
Objectives:
-Describe the differences between community acquired pneumonia and nosocomial pneumonia.
-List the presenting symptoms and diagnostic tests used in the workup of pneumonia.
-List the treatment options for community acquired pneumonia based on patient specific risk factors.
-List the treatment options for nosocomial pneumonia based on patient specific risk factors.
-Describe appropriate pneumonia prevention techniques.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.
Universal Program Number: 048-000-08-017-H01-P
Program Length: 0.1 CEU
Target Audience: Pharmacists
Description:
Mary Ann Tucker, Pharm.D. with Teresa Hoffmann PharmD and Kelly Shields PharmD present and discuss Amiodarone (Cordarone®, Pacerone®), one of the most widely used antiarrhythmic medications and the pharmacist's vital role in ensuring proper use and monitoring of the drug.
Objectives:
Understand the various labeled and unlabeled uses of amiodarone.
Understand the unique mechanism of action and pharmacokinetics of amiodarone and how these factors impact adverse reactions.
Identify the most common adverse drug reactions associated with amiodarone.
Identify necessary monitoring for a patient on long-term amiodarone therapy.
Instructions: For credit card or checking account payment, pay by clicking the button below. You will be redirected to a secure site. Once payment has been received, you will then be directed to the actual course. For all other payment types, contact the Continuing Education Administrative Contact at 419/772-1871.